0
Skip to Content
NMD Pharma
Home
About NMD Pharma
Management team
Our team
Board
Founders
Pipeline
Science
Neuromuscular diseases
Patient insights
Scientific publications
Information for patients
Myasthenia Gravis
Spinal Muscular Atrophy
Charcot-Marie-Tooth
Press releases
Events
Other news
Investors
Your career
Find your job
Contact
NMD Pharma
Home
About NMD Pharma
Management team
Our team
Board
Founders
Pipeline
Science
Neuromuscular diseases
Patient insights
Scientific publications
Information for patients
Myasthenia Gravis
Spinal Muscular Atrophy
Charcot-Marie-Tooth
Press releases
Events
Other news
Investors
Your career
Find your job
Contact
Home
Folder: About
Back
About NMD Pharma
Management team
Our team
Board
Founders
Folder: R&D
Back
Pipeline
Science
Neuromuscular diseases
Patient insights
Scientific publications
Folder: Patients & Clinical Trials
Back
Information for patients
Myasthenia Gravis
Spinal Muscular Atrophy
Charcot-Marie-Tooth
Folder: News
Back
Press releases
Events
Other news
Investors
Folder: Careers
Back
Your career
Find your job
Contact
Events Stine Krag Brunvold 3/10/26 Events Stine Krag Brunvold 3/10/26

Muscular Dystrophy Association (MDA) Clinical & Scientific Conference 2026

Read More
Events Stine Krag Brunvold 1/28/26 Events Stine Krag Brunvold 1/28/26

NMD Pharma at J. P. Morgan Healthcare Conference 2026

Read More
Events Stine Krag Brunvold 5/29/25 Events Stine Krag Brunvold 5/29/25

We’re proud to share a special video marking NMD Pharma’s 10-year anniversary

Read More
Events Stine Krag Brunvold 2/27/25 Events Stine Krag Brunvold 2/27/25

NMD Pharma raises awareness ahead of Rare Disease Day, 2025

Read More
Events Stine Krag Brunvold 11/30/24 Events Stine Krag Brunvold 11/30/24

ClC-1 inhibition for improvement of muscle function in CMT webinar

Read More
Events Stine Krag Brunvold 4/25/24 Events Stine Krag Brunvold 4/25/24

Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma

Read More
Events Stine Krag Brunvold 3/21/24 Events Stine Krag Brunvold 3/21/24

NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine

Read More
Events Stine Krag Brunvold 2/28/23 Events Stine Krag Brunvold 2/28/23

Rare Disease Day, 28 February 2023

Read More
Events Stine Krag Brunvold 10/11/22 Events Stine Krag Brunvold 10/11/22

Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis

Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1

Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2

Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3

Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A

Read More
Events Stine Krag Brunvold 7/7/22 Events Stine Krag Brunvold 7/7/22

An active future made possible by the power of science

Read More

NMD PHARMA A/S, CVR No. 36899069

Cookie Policy Terms of Use Privacy Policy US Expanded Access Policy

Follow us
LinkedIn X Facebook Instagram